ProCE Banner Activity

Practical Concepts and Defining Failure to First-line MF Treatment


Download this slideset from a live symposium at ASCO 2023 to review expert perspectives on practical considerations with treatment for patients with myelofibrosis, including symptom and anemia management and determination of suboptimal response or failure with JAK inhibitors.

Released: June 02, 2023



Ruben A. Mesa

Ruben A. Mesa, MD

Enterprise Cancer Service Line
Executive Director
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Enterprise Senior Vice President
Atrium Health
Vice Dean for Cancer Programs
Wake Forest University School of Medicine
Professor of Medicine
Wake Forest University School of Medicine
Winston-Salem, North Carolina

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by educational grants from AbbVie, Inc., CTI BioPharma, GSK, and Incyte Corporation.

AbbVie, Inc.

CTI BioPharma


Incyte Corporation